Challenges in the design of antibiotic equivalency studies: the multicenter equivalency study of oral amoxicillin versus injectable penicillin in children aged 3-59 months with severe pneumonia

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Patricia L HibberdAmoxicillin Penicillin Pneumonia International Study (APPIS) Group

Abstract

The World Health Organization (WHO) recommends that children with severe pneumonia (characterized by cough or difficult breathing, as well as lower chest wall indrawing) be hospitalized and treated with parenteral penicillin. Oral amoxicillin, if equally effective for treating severe pneumonia, would address challenges associated with providing parenteral therapy, including risk of transmission of bloodborne pathogens from contaminated needles, exposure to nosocomial pathogens during hospitalization, inadequate access to health care facilities, and cost. The recently completed multicenter international trial of oral amoxicillin versus parenteral penicillin for treatment of severe pneumonia demonstrated the equivalency of these agents in children with severe pneumonia. This article focuses on the challenges of designing an equivalence study and the threats to the validity of the trial results, particularly the implications of the bias toward finding equivalence when subjects are unlikely to respond to either study therapy. These considerations have implications for use of the Amoxicillin Penicillin Pneumonia International Study (APPIS) results in clinical practice and for potential modification of WHO treatment guidelines.

References

Mar 1, 1986·Pediatric Infectious Disease·F Shann
Sep 2, 1999·Lancet·K Mulholland
Sep 15, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J G BartlettM J Fine
May 24, 2001·The New England Journal of Medicine·A Hróbjartsson, P C Gøtzsche
Sep 22, 2001·The New England Journal of Medicine·E J Emanuel, F G Miller
Feb 8, 2002·The New England Journal of Medicine·Kenneth McIntosh
Jul 12, 2002·The New England Journal of Medicine·Sam Horng, Franklin G Miller
Oct 17, 2002·Clinics in Perinatology·Richard A van LingenDick Tibboel
Oct 18, 2002·Lancet·Chifumbe ChintuUNKNOWN UNZA-UCLMS Project Paediatric Post-mortem Study Group
Oct 24, 2002·Controlled Clinical Trials·Shein-Chung Chow, Jun Shao
May 22, 2003·JAMA : the Journal of the American Medical Association·Nick FreemantleCarl Griffin
May 22, 2003·JAMA : the Journal of the American Medical Association·Michael S Lauer, Eric J Topol

❮ Previous
Next ❯

Citations

Jun 30, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Chi-Tai FangShan-Chwen Chang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.